Fund Holdings — Flagship Pioneering Inc.

Total Portfolio Value
$334.22M
Total Bought
$0
Total Sold
$2.78M
Net Transaction
-$2.78M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Seres Therapeutics Inc(MCRB)23,117,04523,117,045021,87119,2525.76%-2,619
Syros Pharmaceuticals Inc1,293,8490-1,293,8492,7820—-2,782
Omega Therapeutics Inc29,225,57929,225,579035,65521,7916.52%-13,865
Foghorn Therapeutics Inc(FHTX)12,674,12012,674,1200117,99659,82217.90%-58,174
Sana Biotechnology Inc(SANA)25,001,85625,001,8560104,00840,75312.19%-63,255
Moderna Inc(MRNA)4,632,1494,632,1490309,567192,60557.63%-116,962
Page 1 of 1
Flagship Pioneering Inc. — 13F Holdings — Q4 2024 | TickerTrail